NCT06899763View on ClinicalTrials.gov

Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy

CompletedOBSERVATIONAL

Enrollment

6

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2024

Conditions

Hepatocellular Carcinoma (HCC)MASLD-HCCHCV_HCC

Trial Locations (1)

27100

Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia

All Listed Sponsors

lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER